The impact of M&As on company innovation: evidence from the US medical device industry

被引:0
|
作者
Chih-Hao Lin
Show-Ling Jang
机构
[1] National Taiwan University,School of Medicine
[2] National Taiwan University,Department of Law, College of Law
[3] National Taiwan University,Department of Economics, School of Social Sciences
来源
Scientometrics | 2010年 / 84卷
关键词
US medical device industry; M&A; Patent stock; Patent diversity;
D O I
暂无
中图分类号
学科分类号
摘要
The acquisition of new technologies represents a vitally important and fundamental goal of many corporate managers, particularly those within the medical device industry. We collect data on ten medical device companies as our sample in this study, covering the period from 1990 to 2006; this sample is drawn from the top 20 companies in the US, on the basis of international sales performance. We also collect details on all of the acquisitions undertaken by these companies, along with their patenting performance. The empirical results of this study suggest that technological acquisitions are only likely to be of help to the acquiring firms, in terms of improving their innovative performance, if they set out to acquire those companies that are in similar proximity, in terms of their technological field. There is also a clear need for such acquiring firms to ensure their continuing commitment to internal R&D investment in order to maintain their own versatility.
引用
收藏
页码:119 / 131
页数:12
相关论文
共 50 条
  • [41] Implicit regulation in M&As: Evidence from voluntary earnouts in China
    Zeng, Wen
    Yin, Huifang
    CHINA JOURNAL OF ACCOUNTING RESEARCH, 2024, 17 (02)
  • [42] Assessing Innovation Management in a Company from the Steel Industry
    Varandas Junior, Angelo
    Cauchick Miguel, Paulo Augusto
    Salerno, Mario Sergio
    PICMET '12: PROCEEDINGS - TECHNOLOGY MANAGEMENT FOR EMERGING TECHNOLOGIES, 2012, : 1942 - 1952
  • [43] Asian innovation in pharmaceutical and medical device industry - beyond tomorrow
    Jakovljevic, Mihajlo
    Wu, Wenqing
    Merrick, Joav
    Cerda, Arcadio
    Varjacic, Mirjana
    Sugahara, Takuma
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 : 42 - 50
  • [44] The Bleeding Edge: Documenting Innovation and Injury in the Medical Device Industry
    Pendyal, Akshay
    Ross, Joseph S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (03): : 190 - 192
  • [45] Trust and inter-regional M&As: Evidence from China
    Wang, Zhenshan
    Xu, Huilin
    INTERNATIONAL REVIEW OF ECONOMICS & FINANCE, 2024, 92 : 796 - 818
  • [46] The impact of regulatory review time on incremental and radical innovation: evidence from the high-risk medical device market
    Onur, Ilke
    Soderberg, Magnus
    JOURNAL OF REGULATORY ECONOMICS, 2020, 57 (02) : 134 - 158
  • [47] The impact of regulatory review time on incremental and radical innovation: evidence from the high-risk medical device market
    Ilke Onur
    Magnus Söderberg
    Journal of Regulatory Economics, 2020, 57 : 134 - 158
  • [48] Value maximization and open innovation in food and beverage industry: evidence from US market
    Miglietta, Nicola
    Battisti, Enrico
    Campanella, Francesco
    BRITISH FOOD JOURNAL, 2017, 119 (11): : 2477 - 2492
  • [49] Forces reshaping the performance and contribution of the US medical device industry
    Benson, JS
    FOOD AND DRUG LAW JOURNAL, 1996, 51 (02): : 331 - 336
  • [50] ORGANISATIONAL LEARNING SEQUENCES IN TECHNOLOGICAL INNOVATION: EVIDENCE FROM THE BIOPHARMACEUTICAL AND MEDICAL DEVICE SECTORS
    Seidle, Russell
    INTERNATIONAL JOURNAL OF INNOVATION MANAGEMENT, 2015, 19 (03)